BIOMAT Database Logo BIOMAT Database Logo

Serum protein profile of rheumatoid arthritis treated with anti-TNF therapy (infliximab). 2007

Tohru Takeuchi, and Toyofumi Nakanishi, and Yoko Tabushi, and Ayu Hata, and Takeshi Shoda, and Takuya Kotani, and Akira Shimizu, and Takayuki Takubo, and Shigeki Makino, and Toshiaki Hanafusa
First Department of Internal Medicine, Osaka Medical College, Daigaku-Machi 2-7, Takatsuki, Osaka 569-8686, Japan. t-takeuchi@poh.osaka-med.ac.jp

We analyzed the changes in the serum protein profile by infliximab using two-dimensional gel electrophoresis and mass spectrometry. More than 50 gel spots were seen to increase or decrease in correlation with clinical improvements of RA. The spots corresponding to CRP, C3, and Apo J showed reduced staining intensity, while the spots corresponding to Apo A-I, RBP, and transthyretin were enhanced. The protein profile of RA patients treated with infliximab was mostly similar to that of normal healthy controls except for several protein spots. This suggested that infliximab normalized the serum protein profile of RA patients, leading to modification in the serum lipid profile and antioxidant status in RA.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002846 Chromatography, Affinity A chromatographic technique that utilizes the ability of biological molecules, often ANTIBODIES, to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Bioaffinity,Immunochromatography,Affinity Chromatography,Bioaffinity Chromatography
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069285 Infliximab A chimeric monoclonal antibody to TNF-ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE. Inflectra,Infliximab-abda,Infliximab-dyyb,MAb cA2,Monoclonal Antibody cA2,Remicade,Renflexis,Antibody cA2, Monoclonal,Infliximab abda,Infliximab dyyb,cA2, Monoclonal Antibody
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Tohru Takeuchi, and Toyofumi Nakanishi, and Yoko Tabushi, and Ayu Hata, and Takeshi Shoda, and Takuya Kotani, and Akira Shimizu, and Takayuki Takubo, and Shigeki Makino, and Toshiaki Hanafusa
Pneumonitis caused by Legionella pneumoniae in a patient with rheumatoid arthritis treated with anti-TNF-alpha therapy (infliximab).
April 2005, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases,
Tohru Takeuchi, and Toyofumi Nakanishi, and Yoko Tabushi, and Ayu Hata, and Takeshi Shoda, and Takuya Kotani, and Akira Shimizu, and Takayuki Takubo, and Shigeki Makino, and Toshiaki Hanafusa
Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab.
January 2017, Mediators of inflammation,
Tohru Takeuchi, and Toyofumi Nakanishi, and Yoko Tabushi, and Ayu Hata, and Takeshi Shoda, and Takuya Kotani, and Akira Shimizu, and Takayuki Takubo, and Shigeki Makino, and Toshiaki Hanafusa
Changes in serum adipokines profile and insulin resistance in patients with rheumatoid arthritis treated with anti-TNF-α.
December 2019, Current medical research and opinion,
Tohru Takeuchi, and Toyofumi Nakanishi, and Yoko Tabushi, and Ayu Hata, and Takeshi Shoda, and Takuya Kotani, and Akira Shimizu, and Takayuki Takubo, and Shigeki Makino, and Toshiaki Hanafusa
[Anti-TNF therapy in rheumatoid arthritis].
February 2004, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology,
Tohru Takeuchi, and Toyofumi Nakanishi, and Yoko Tabushi, and Ayu Hata, and Takeshi Shoda, and Takuya Kotani, and Akira Shimizu, and Takayuki Takubo, and Shigeki Makino, and Toshiaki Hanafusa
Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies.
December 2007, Rheumatology (Oxford, England),
Tohru Takeuchi, and Toyofumi Nakanishi, and Yoko Tabushi, and Ayu Hata, and Takeshi Shoda, and Takuya Kotani, and Akira Shimizu, and Takayuki Takubo, and Shigeki Makino, and Toshiaki Hanafusa
Treatment with anti-TNF-alpha antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis.
April 2007, Clinical rheumatology,
Tohru Takeuchi, and Toyofumi Nakanishi, and Yoko Tabushi, and Ayu Hata, and Takeshi Shoda, and Takuya Kotani, and Akira Shimizu, and Takayuki Takubo, and Shigeki Makino, and Toshiaki Hanafusa
Serum protein oxidation in patients with rheumatoid arthritis and effects of infliximab therapy.
October 2006, Clinica chimica acta; international journal of clinical chemistry,
Tohru Takeuchi, and Toyofumi Nakanishi, and Yoko Tabushi, and Ayu Hata, and Takeshi Shoda, and Takuya Kotani, and Akira Shimizu, and Takayuki Takubo, and Shigeki Makino, and Toshiaki Hanafusa
Serum protein profile of Crohn's disease treated with infliximab.
November 2013, Journal of Crohn's & colitis,
Tohru Takeuchi, and Toyofumi Nakanishi, and Yoko Tabushi, and Ayu Hata, and Takeshi Shoda, and Takuya Kotani, and Akira Shimizu, and Takayuki Takubo, and Shigeki Makino, and Toshiaki Hanafusa
Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis.
March 2006, Clinica chimica acta; international journal of clinical chemistry,
Tohru Takeuchi, and Toyofumi Nakanishi, and Yoko Tabushi, and Ayu Hata, and Takeshi Shoda, and Takuya Kotani, and Akira Shimizu, and Takayuki Takubo, and Shigeki Makino, and Toshiaki Hanafusa
Rheumatoid arthritis and anti-TNF-alpha therapy.
July 2005, Atherosclerosis,
Copied contents to your clipboard!